Keyword: rare diseases

News

AstraZeneca to Buy Amolyt Pharma for up to $1.05 Billion

15.03.2024 -

Britain's AstraZeneca is to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases, more than $1...

News

Ultragenyx Opens Gene Therapy Manufacturing Plant

26.06.2023 -

US biopharma Ultragenyx Pharmaceutical has opened a gene therapy manufacturing facility in Bedford, Massachusetts, USA. The company said it is one of the first in the US...

News

Sweden’s Sobi Agrees Merger with CTI BioPharma

15.05.2023 -

Swedish Orphan Biovitrum (Sobi) has agreed a merger with CTI BioPharma, a US biopharmaceutical company focused on blood-related cancers and rare diseases. Through a...

News

Chiesi Closes Amryt Acquisition

18.04.2023 -

Italian biopharma Chiesi has completed its acquisition of Irish rare disease drugmaker Amryt Pharma. The deal, which was originally announced in January, could be worth...

News

Amgen Boosts Rare Diseases with Horizon Buy

15.12.2022 -

Amgen has agreed to buy Horizon Therapeutics for $28.3 billion including debt, boosting its portfolio of drugs for rare autoimmune and inflammatory diseases and beating...

News

Evotec Enhances Rare Disease Focus with Central Glass Buy

30.08.2022 -

German CDMO Evotec is to acquire compatriot company Central Glass Germany from Japanese owner Central Glass for a nominal price of €1. The transaction, which remains...

News

Mallinckrodt to buy Sucampo Pharmaceuticals

05.01.2018 - Specialty pharmaceuticals manufacturer Mallinckrodt has agreed to buy biopharmaceuticals producer Sucampo, including its commercial and development assets. The transaction is...

News

Ergomed Buys Dutch-based PSR Group

05.10.2017 - UK pharmaceutical company Ergomed has acquired PSR Group, a Dutch contract research organization (CRO) that specializes in orphan drug development and is regarded as a leading...